-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Rein Therapeutics, Lowers Price Target to $8

Benzinga·06/01/2026 10:42:16
Listen to the news
HC Wainwright & Co. analyst Brandon Folkes maintains Rein Therapeutics (NASDAQ:RNTX) with a Buy and lowers the price target from $10 to $8.